Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2026-06-29 @ 8:30 PM
Study NCT ID:
NCT02268851
Status:
COMPLETED
Last Update Posted:
2024-11-15
First Post:
2014-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL
Sponsor:
Organization: